ZBIO

⇓ Download page

Zenas BioPharma, Inc. · 2 run(s) on file · sizing: $40,000–$50,000 · Press

79.3

Conviction

84.7

Technical

$40k–$50k

PRESS

Bands:Lines:

Filled red = a hard gate was breached that run. Shaded bands: red <40 (no trade), amber 40–60 (probe), green 60–75 (standard), 75–85 (press), 85+ (top tier).

Every run

newest first

Date	Conviction	Technical	Stage	Gated	Sizing	Close	Who bought	Source
25 Aug 2026	79.3	84.7	Early Trend Expansion	no	$40,000–$50,000 · Press	33.77	3 CEO, 3 Director	ticker
22 Aug 2026	80.1	85.8	Early Trend Expansion	no	$40,000–$50,000 · Press	32.29	3 CEO, 3 Director	ticker

← back to runs · JSON

Ask about ZBIO

Ask about the stored scores, gates, insider activity, technical structure, or what changed between runs.

Provider setup needed

I can explain ZBIO using Stock Sleuth’s stored evidence once a language model provider is connected.

Latest analysis report

Earnings calls

Running in demo mode — transcripts are only available for a small set of demo tickers (e.g. AAPL). Get a free or paid API key at earningscall.biz/api-pricing and set the EARNINGSCALL_API_KEY secret to unlock 5,000+ companies.